Xianqing Mao

Latest publications

The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.

  • Cytoskeleton and Cancer Progression
September 22, 2016
2016 Sep. Oncogene.35(38):5043-55. Epub 2016 Apr 4.
By:
  • Mao X
  • Gauche C
  • Coughtrie MW
  • Bui C
  • Gulberti S
  • Merhi-Soussi F
  • Ramalanjaona N
  • Bertin-Jung I
  • Diot A
  • Dumas D
  • De Freitas Caires N
  • Thompson AM
  • Bourdon JC
  • Ouzzine M
  • Fournel-Gigleux S.

CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.

  • Cytoskeleton and Cancer Progression
  • NORLUX-Glioma Biology
  • Tumor Microenvironment
March 22, 2016
2016 Mar. Oncotarget.7(12):13688-705.
By:
  • Hoffmann C
  • Mao X
  • Dieterle M
  • Moreau F
  • Al Absi A
  • Steinmetz A
  • Oudin A
  • Berchem G
  • Janji B
  • Thomas C.

HaloTag is an effective expression and solubilisation fusion partner for a range of fibroblast growth factors.

  • Cytoskeleton and Cancer Progression
June 25, 2015
2015 Jun. PeerJ.3:e1060.
By:
  • Sun C
  • Li Y
  • Taylor SE
  • Mao X
  • Wilkinson MC
  • Fernig DG.

The role of quantitative changes in the epxression of insulin receptor substrate-1 and nuclear ubiquitin in abnormal glycometabolism in the livers of KKay mice and the relative therapeutic mechanisms of Astragalus polysaccharide.

  • Cytoskeleton and Cancer Progression
February 01, 2014
2014 Feb. Int J Mol Med.33(2):341-50. Epub 2013 Dec 9.
By:
  • Ye Y
  • Deng T
  • Wan XY
  • Ouyang JP
  • Liu M
  • Mao XQ.